Google+ Facebook Twitter Twitter

Tech news: December 2023

This month's top tech news stories


Gene therapy

Gene therapy has emerged as the most popular approach employed by academic institutes, biotechs, and NGOs in the treatment of rare diseases, according to the latest findings in Inpart’s rare disease Global Challenge report. It shows an increase in therapeutic strategies to treat rare diseases, with small molecule orphan drug discovery and protein or other biologics following closely behind on the list of focus areas for research collaborations. Gene therapy makes up 24% of total interactions from companies who engaged.

Cancer Research UK

Therapeutic cancer agents

Cancer Research UK, and the KWF Dutch Cancer Society – two of the world’s largest charitable funders of cancer research – have announced a new multi-project strategic partnership to advance promising therapeutic agents for cancer. KWF intends to provide funding to enable the development of select early phase clinical programmes through Cancer Research UK’s Centre for Drug Development (CDD). Cancer Research UK’s CDD will be utilising its 30 years of experience in ushering in first-in-class therapeutics.

Integra Biosciences

Pipetting ebook

Integra Biosciences is pleased to announce the release of a new free ebook providing a complete guide to pipetting. Liquid handling protocols form the backbone of many life sciences workflows, and mastering correct pipetting practices plays a vital role in obtaining reliable experimental results.

The ebook aims to equip readers with the essentials to turn pipetting from a tedious, necessary task into an efficient, accurate and enjoyable one. It covers key subjects such as: different types of pipettes and how to use them, pipetting best practices and tips for maintaining and calibrating.

The ebook will be a useful tool for any scientist looking to achieve high accuracy and precision.

Image credit | Shutterstock | Integra

Related Articles

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Specialist diploma in molecular pathology

On behalf of the members of the Molecular Pathology Advisory Panel, Chair Dr Andrew Blann introduces the new Specialist Diploma.

The role of organelle repair in fighting infection

Research has found that cellular structures act as “molecular plasters” that protect against infections, such as tuberculosis. We talk to study co-author Claudio Bussi.